Old vaccine trains immune system

September 23, 2015
Credit: National Cancer Institute

Not only the acquired immune system but also the innate immune system has a memory. And the BCG vaccine against tuberculosis can stimulate this memory. After a BCG vaccination the innate immune system responds better to a wide range of other infections. Mihai Netea and colleagues from Radboud university medical center discovered and described how that works. They think that the old vaccine could be useful for specific target groups, such as the elderly.

BCG, a vaccine against tuberculosis, was discovered in the 1920s and is one of the most used vaccines worldwide. In the Netherlands, the vaccine no longer falls within the national vaccination program. Now that it is known that the vaccine can give a boost to the , Mihai Netea and his colleagues are calling for more research to determine whether the vaccine can prevent infections in certain risk groups.

During a bacterial infection, monocytes penetrate the infected tissue where they differentiate/ change into macrophages. These carry out the first line of defense: the destruction of the intruder. Monocytes and macrophages are two important of the innate immune system. They respond quickly but attack certain pathogens less specifically. The acquired immune system responds more slowly to an unknown intruder but is specifically targeted at a specific intruder. Furthermore, the acquired immune system has a memory so that it responds faster to the same threat. For a long time it was thought that this memory was an exclusive characteristic of the acquired immune system. However research by Mihai Netea has revealed that this is not the case. The innate immune system also has a memory but this is not specific. Netea and his colleagues refer to this as 'trained immunity'.

Hidden DNA

Shortly after the introduction of the BCG vaccine it was noticed that not only tuberculosis occurred less frequently but that young children also died less due to other pathogens. On September 22, 2015 Johanneke Kleinnijenhuis from Netea's group will defend her doctoral thesis for her research into a biological explanation for the non-specific effects of BCG. In volunteers who received a BCG vaccination, she observed an increase in cytokine production (proteins that control ) and in the number of receptors that play a role during the recognition of intruders. This effect was sustained until three months after vaccination. The scientists discovered that this was because the DNA required was more easily reachable. Netea: "The DNA needs to be read out for the required proteins to be produced. Prior to the vaccination the DNA was hidden so to speak and was consequently difficult to read out. Vaccination ensures that the DNA is exposed."

The researchers also examined the effect in an animal model. Mice without cells from the acquired immune system were administered a potentially lethal quantity of the fungus Candida albicans. One part of the group received a BCG vaccination two weeks before this and the other part received a placebo. The BCG-vaccinated animals all survived the fungal infection, whereas in the placebo group more than half of the animals died. As a result of this study the researchers concluded that the effects can be ascribed to the innate immune system.

According to the researchers, the trainability of cells from the innate opens up many opportunities for applications. Netea: "I do not think it is worthwhile introducing BCG again on a large-scale but it would be useful to target it at specific groups. One such example is elderly people who are discharged from hospital and who often experience a relapse when they are back home again. Another possible use is as a booster for other vaccines." In the coming years the researchers want to investigate such applications.

Explore further: How 'trained immunity' mediates BCG therapy of bladder cancer

Related Stories

How 'trained immunity' mediates BCG therapy of bladder cancer

October 30, 2014
Bacillus Calmette-Guerin (BCG) is a vaccine widely used in low and middle-income countries to protect against childhood tuberculosis. Besides its specific anti-tuberculosis effects, BCG can also function as a general immune-booster, ...

Clinical trials of VPM1002 as a tuberculosis vaccine in newborns

March 24, 2015
The only tuberculosis vaccine currently approved, the Bacillus Calmette-Guérin (BCG) vaccine, protects children from the most severe forms of the disease in most cases but does not provide protection against the most common ...

Innate immunity may help limit cancer growth

September 17, 2015
Cancer immunotherapy, a relatively new frontier in cancer treatment, works by enhancing the capacity of one's immune system to attack cancer cells. To date, this field has focused on developing cancer vaccines or engineering ...

Effects of MVA85A vaccine on tuberculosis

September 9, 2015
A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children.

Common tuberculosis vaccine can be used to prevent infection as well as disease

August 5, 2014
The vaccine used to protect against tuberculosis disease (bacillus calmette-guerin or BCG) also protects against tuberculosis infection (mycobacterium) as well as protecting against progression from infection to disease, ...

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

Cholesterol-like molecules switch off the engine in cancer-targeting 'Natural Killer' cells

September 18, 2017
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.